Diabetes

Advancements in diabetes treatment have highlighted the potential of stem cell therapy and exosome therapy to provide regenerative and potentially curative approaches.
Therapy

Stem cell therapy

Stem cell therapy for diabetes primarily focuses on the differentiation of stem cells into insulin-producing beta cells. Types of stem cells used include embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). These stem cells can be coaxed into becoming beta cells, which can then be transplanted into the patient to restore insulin production.

This approach aims to address the root cause of diabetes, especially Type 1 diabetes, where the immune system destroys beta cells. Recent research has shown that stem cell-derived beta cells can effectively produce insulin and regulate blood sugar levels in animal models. Clinical trials are underway to assess their safety and efficacy in humans. However, challenges such as ensuring the survival and proper functioning of transplanted cells, as well as preventing immune rejection, still need to be addressed.

Therapy

Exosome therapy

Exosome therapy leverages exosomes, small extracellular vesicles secreted by cells, which contain bioactive molecules like proteins, lipids, and RNA. Exosomes derived from stem cells can modulate immune responses and promote tissue repair. In the context of diabetes, exosomes have shown potential in reducing inflammation, protecting beta cells from autoimmune attacks, and enhancing their function. Additionally, exosomes can carry therapeutic molecules that promote beta cell regeneration and improve insulin sensitivity. Their small size and ability to cross biological barriers make exosomes an attractive option for diabetes treatment, with lower risks of immune rejection compared to whole-cell transplants.

Combining stem cell and exosome therapies could offer a comprehensive approach to diabetes treatment by providing both new insulin-producing cells and supportive factors that enhance their survival and function. While these therapies are still under research and development, they hold significant promise for offering long-term solutions and improving the quality of life for diabetes patients.

Our Doctors

A Professional &
Care Provider

Dr. Abdulsamet Günay

Pediatric Health and Diseases Specialist

Dr. Banu Yildirim

Pediatric Health and Diseases Specialist

Dr. Süleyman Gülsen

Pediatric Health and Diseases Specialist